Welcome
We are a specialty pharmaceutical company developing a new generation of pharmaceutical and biopharmaceutical products using our proprietary drug formulation technologies.
Eurand is proud to be a member of the following organizations:
Featured technology
Our Diffucaps® technology is a multiparticulate system that provides optimal release profiles for either single drugs or for a combination of drugs.
Read more about featured technology
Featured products
-
EUR-1008 (Zenpep™)
EUR-1008 is a new proprietary product developed for the treatment of Exocrine Pancreatic Insufficiency, commonly associated with cystic fibrosis and chronic pancreatitis. The NDA is currently under review; approvable letter issued by the FDA June 2008.
Read more about EUR-1008 (Zenpep™) 